Literature DB >> 11181525

The androgen receptor (AR) amino-terminus imposes androgen-specific regulation of AR gene expression via an exonic enhancer.

J M Grad1, L S Lyons, D M Robins, K L Burnstein.   

Abstract

Androgen and glucocorticoid receptor (AR, GR), two closely related members of the nuclear receptor superfamily, can recognize a similar cis-acting DNA sequence, or hormone response element (HRE). Despite this apparent commonality, these receptors regulate distinct target genes in vivo. The AR gene itself is regulated by AR but not GR in a variety of cell types, including osteoblast-like cells, as shown here. To understand this specificity, we first identified the DNA sequences responsible for androgen-mediated up-regulation of AR messenger RNA. A 6.5-kb region encompassing exon D, intron 4, and exon E of the AR gene contains four exonic HREs and exhibits cell type-specific, AR-mediated transcriptional enhancement when placed upstream of a heterologous promoter and reporter gene. A 350-bp fragment consisting of just exons D and E exhibits the same cell- and androgen-specificity as the 6.5-kb region, as well as the native AR gene. Consistent with a role for the exonic HREs, androgen regulation via this intragenic enhancer requires the HREs as well as a functional receptor DNA binding domain. A panel of AR/GR chimeric receptors was used to test which AR domains (amino-terminal, DNA binding or ligand binding) confer androgen-specific regulation of the 350-bp enhancer. Only chimeric receptors containing the amino-terminus of AR induced reporter gene activity from the AR gene enhancer. Further, a constitutively active AR consisting of only the AR amino-terminus and DNA binding domain (AA phi) retained the capacity to activate the internal responsive region, unlike a constitutively active chimera harboring the GR amino-terminus and AR DNA binding domain (GA phi). Thus, the AR amino terminus is the sole determinant for androgen-specific regulation of the AR gene internal enhancer. These findings support a model in which the amino termini of ARs bound to HREs within the AR gene interact with an exclusive auxiliary factor(s) to elicit androgen-specific regulation of AR messenger RNA. This is the first example of androgen-specific response in which the necessary and sufficient distinguishing capacity resides within the AR amino terminus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181525     DOI: 10.1210/endo.142.3.8049

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  Identification of testosterone-/androgen receptor-regulated genes in mouse Sertoli cells.

Authors:  Qiao-Xia Zhang; Xiao-Yan Zhang; Zhen-Ming Zhang; Wei Lu; Ling Liu; Gang Li; Zhi-Ming Cai; Yao-Ting Gui; Chawnshang Chang
Journal:  Asian J Androl       Date:  2011-10-17       Impact factor: 3.285

2.  StuI polymorphism on the androgen receptor gene is associated with recurrent spontaneous abortion.

Authors:  Tahere Jahaninejad; Nasrin Ghasemi; Seyyed Mehdi Kalantar; Mohammad Hasan Sheikhha; Hossein Pashaiefar
Journal:  J Assist Reprod Genet       Date:  2013-02-22       Impact factor: 3.412

3.  Association between G1733A (rs6152) polymorphism in androgen receptor gene and recurrent spontaneous abortions in Mexican population.

Authors:  Ángela Porras-Dorantes; Aniel Jessica Leticia Brambila-Tapia; Alma Benita Lazcano-Castellanos; Thiago Donizete Da Silva-José; Jesús Alejandro Juárez-Osuna; José Elías García-Ortiz
Journal:  J Assist Reprod Genet       Date:  2017-07-13       Impact factor: 3.412

4.  A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor.

Authors:  Marco P Licciardello; Anna Ringler; Patrick Markt; Freya Klepsch; Charles-Hugues Lardeau; Sara Sdelci; Erika Schirghuber; André C Müller; Michael Caldera; Anja Wagner; Rebecca Herzog; Thomas Penz; Michael Schuster; Bernd Boidol; Gerhard Dürnberger; Yasin Folkvaljon; Pär Stattin; Vladimir Ivanov; Jacques Colinge; Christoph Bock; Klaus Kratochwill; Jörg Menche; Keiryn L Bennett; Stefan Kubicek
Journal:  Nat Chem Biol       Date:  2017-05-22       Impact factor: 15.040

5.  Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia.

Authors:  Axel M Hillmer; Sandra Hanneken; Sibylle Ritzmann; Tim Becker; Jan Freudenberg; Felix F Brockschmidt; Antonia Flaquer; Yun Freudenberg-Hua; Rami Abou Jamra; Christine Metzen; Uwe Heyn; Nadine Schweiger; Regina C Betz; Bettina Blaumeiser; Jochen Hampe; Stefan Schreiber; Thomas G Schulze; Hans Christian Hennies; Johannes Schumacher; Peter Propping; Thomas Ruzicka; Sven Cichon; Thomas F Wienker; Roland Kruse; Markus M Nothen
Journal:  Am J Hum Genet       Date:  2005-05-18       Impact factor: 11.025

6.  The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells.

Authors:  Seung-Keun Hong; Jin-Hwan Kim; Ming-Fong Lin; Jong-In Park
Journal:  Exp Cell Res       Date:  2011-08-16       Impact factor: 3.905

7.  Endothelin-1 enhances the expression of the androgen receptor via activation of the c-myc pathway in prostate cancer cells.

Authors:  June G Lee; Rong Zheng; Jennifer M McCafferty-Cepero; Kerry L Burnstein; David M Nanus; Ruoqian Shen
Journal:  Mol Carcinog       Date:  2009-02       Impact factor: 4.784

Review 8.  Reflections on the diseases linked to mutations of the androgen receptor.

Authors:  Angelo Poletti; Paola Negri-Cesi; Luciano Martini
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.925

Review 9.  Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects.

Authors:  R Ferraldeschi; J Welti; J Luo; G Attard; J S de Bono
Journal:  Oncogene       Date:  2014-05-19       Impact factor: 9.867

10.  An ultraconserved Hox-Pbx responsive element resides in the coding sequence of Hoxa2 and is active in rhombomere 4.

Authors:  Xavier Lampe; Omar Abdel Samad; Allan Guiguen; Christelle Matis; Sophie Remacle; Jacques J Picard; Filippo M Rijli; René Rezsohazy
Journal:  Nucleic Acids Res       Date:  2008-04-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.